NDC codes

FDA NDC Directory
Product NDC (as listed)72893-017Labeler and product segments. Claims need a package NDC.
Product NDC at billing width72893-0017Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
72893-017-0772893001707728930017071 TUBE in 1 CARTON (72893-017-07) / 3 g in 1 TUBEMarketed from Feb 25, 2026
72893-017-0872893001708728930017081 TUBE in 1 CARTON (72893-017-08) / 27 g in 1 TUBEMarketed from Feb 25, 2026
72893-017-0972893001709728930017091 TUBE in 1 CARTON (72893-017-09) / 85 g in 1 TUBEMarketed from Feb 25, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Adquey
Generic name (nonproprietary)
difamilast
Active ingredients
Difamilast — 10 mg/g
Dosage form
Ointment
Route
Topical
Labeler
Acrotech Biopharma IncNDC labeler code 72893
Product type
Prescription drug
Marketing category
NDA — New Drug ApplicationApplication NDA 219474
Marketing start
Listing expires
Other FDA classes
Phosphodiesterase 4 Inhibitors (Mechanism)
Identifiers
Product ID 72893-017_4b8a157b-05ab-49a7-bd3a-b5a5d0b6f679SPL ID 4b8a157b-05ab-49a7-bd3a-b5a5d0b6f679SPL set ID 46c95e41-fa29-4e11-9d94-0fd4f0291c34RxCUI 2738419, 2738424UNII T3U32GLJ0FUPC 0372893017091, 0372893017084
Pharmacologic class
Phosphodiesterase 4 Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472893001707 followed by a unit qualifier and the quantity

Package 72893-0017-07. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

ADQUEY is indicated for the topical treatment of adults and pediatric patients 2 years of age and older with mild to moderate atopic dermatitis. ADQUEY is a phosphodiesterase 4 inhibitor indicated for the topical treatment of adults and pediatric patients 2 years of age and older with mild to moderate atopic dermatitis. (1)

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 72893-017

What is NDC 72893-017?
72893-017 is the product NDC for Adquey (difamilast), Difamilast 10 mg/g ointment, listed with the FDA by Acrotech Biopharma Inc. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Adquey (Difamilast).
What is the active ingredient?
Difamilast.
Who is the labeler?
Acrotech Biopharma Inc, NDC labeler code 72893. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Adquey?
None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Free account

Log in to keep searching

You’ve used your 3 free searches. Med-Code is free: log in or create a free profile to keep looking up NDCs, J-codes and drugs.

Create a free profileLog in